Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

303
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
303

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer.

The Journal of clinical investigation·2026
Same author

Hospital-Level Variation in Antenatal Corticosteroids for Late Preterm Births.

medRxiv : the preprint server for health sciences·2026
Same author

Robotic vs laparoscopic interval cytoreductive surgery in stage III ovarian cancer: an analysis of the National Cancer Database.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Frequency of lymph node involvement in clinically early-stage low-grade serous ovarian cancer: a systematic review and meta-analysis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Antenatal Steroid Exposure among Late Preterm Births Following Updated Clinical Guidance.

medRxiv : the preprint server for health sciences·2026
Same author

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Related Experiment Video

Updated: May 13, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.8K

Secondary databases in gynecologic cancer research.

Katherine Hicks-Courant1, Emily Meichun Ko2, Koji Matsuo3

  • 1Ann B. Barshinger Cancer Institute, Lancaster General Health, Lancaster, Pennsylvania, USA; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|April 14, 2025
PubMed
Summary

This review clarifies the strengths and weaknesses of large cancer databases like NCDB and SEER for gynecologic oncology research. Understanding these datasets improves the interpretation and application of study findings.

Keywords:
Cost-Benefit AnalysisCost-Effectiveness AnalysisCosts and Cost AnalysisCross-Sectional StudiesRetrospective Study

More Related Videos

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.0K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.0K

Related Experiment Videos

Last Updated: May 13, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.8K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.0K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.0K

Area of Science:

  • Gynecologic Oncology
  • Health Services Research
  • Biostatistics

Background:

  • Large observational and cohort studies are crucial in gynecologic oncology.
  • Understanding the characteristics of commonly used research databases is essential for accurate interpretation of findings.
  • Researchers need to be aware of both the advantages and limitations of these data sources.

Purpose of the Study:

  • To provide a comprehensive overview of major databases used in gynecologic oncology research.
  • To detail the data, access, management, and limitations of key databases.
  • To enhance the effective use and evaluation of research utilizing these datasets.

Main Methods:

  • Review of prominent databases including NCDB, SEER, SEER-Medicare, MarketScan, HCUP, NSQIP, and Premier.
  • Description of data content, accessibility, and management protocols for each database.
  • Analysis of the highlights and limitations inherent to each data source.

Main Results:

  • Detailed descriptions of seven major databases used in gynecologic oncology research.
  • Identification of specific strengths and weaknesses for each database.
  • Guidance on interpreting and applying results from studies using these datasets.

Conclusions:

  • A thorough understanding of database specifics aids in the critical evaluation of gynecologic oncology research.
  • Improved knowledge of datasets facilitates the development of practice-changing studies.
  • This review empowers researchers, reviewers, and readers to better utilize and interpret findings from large-scale studies.